Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

NCT00954122 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca